Karine Chemin

Solna, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Dnmt3a Mutations Limit Normal and Autoreactive CD4+ T Follicular Helper Responses and Attenuate T Cell-Driven Joint Inflammation.

Dnmt3a Mutations Limit Normal and Autoreactive CD4+ T Follicular Helper Responses and Attenuate T Cell-Driven Joint Inflammation.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: December 15, 2025

Pan-disease blood protein profiles of rheumatic autoimmune diseases.

Pan-disease blood protein profiles of rheumatic autoimmune diseases.

Journal: Communications medicine

Published: December 12, 2025

Anti-MDA5 monoclonal antibodies from patients with dermatomyositis - B cell characteristics and differential targeting of the helicase domains.

Anti-MDA5 monoclonal antibodies from patients with dermatomyositis - B cell characteristics and differential targeting of the helicase domains.

Journal: Journal of autoimmunity

Published: November 20, 2025

CD72 downregulation on DN2 B cells is associated with disease activity and resistance to rituximab in systemic lupus erythematosus.

CD72 downregulation on DN2 B cells is associated with disease activity and resistance to rituximab in systemic lupus erythematosus.

Journal: Rheumatology (Oxford, England)

Published: October 28, 2025

Autoreactive T cells identified in patients with anti-Jo1+ antisynthetase syndrome recognise a new epitope on histidyl t-RNA synthetase.

Autoreactive T cells identified in patients with anti-Jo1+ antisynthetase syndrome recognise a new epitope on histidyl t-RNA synthetase.

Journal: Annals of the rheumatic diseases

Published: August 01, 2025

Structure-based screening and a conformational biosensor identify a GPR183 inverse agonist and an activation switch.

Structure-based screening and a conformational biosensor identify a GPR183 inverse agonist and an activation switch.

Journal: Nature communications

Published: July 14, 2025

Targeting NFATc1-regulated MTHFD2 one-carbon metabolism to suppress sustained T-cell-mediated inflammation in rheumatoid arthritis.

Targeting NFATc1-regulated MTHFD2 one-carbon metabolism to suppress sustained T-cell-mediated inflammation in rheumatoid arthritis.

Journal: Signal transduction and targeted therapy

Published: July 04, 2025

Innate immune cell subsets are enriched in synovial fluid of ACPA-negative rheumatoid arthritis and characterized by distinct type I IFN gene signatures.

Innate immune cell subsets are enriched in synovial fluid of ACPA-negative rheumatoid arthritis and characterized by distinct type I IFN gene signatures.

Journal: Annals of the rheumatic diseases

Published: January 29, 2025

Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritis.

Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritis.

Journal: RMD open

Published: May 09, 2024

Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domains.

Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domains.

Journal: Rheumatology (Oxford, England)

Published: April 13, 2023

Occurrence and localization of FOXP3 + cells in kidney biopsies in lupus nephritis and ANCA-associated vasculitis.

Occurrence and localization of FOXP3 + cells in kidney biopsies in lupus nephritis and ANCA-associated vasculitis.

Journal: Clinical rheumatology

Published: March 19, 2023

Citrulline immunity in RA: CD8+ T cells enter the scene.

Citrulline immunity in RA: CD8+ T cells enter the scene.

Journal: Nature reviews. Rheumatology

Published: March 14, 2023

Showing 1-12 of 35

Last Updated: 09/26/2026